Gynecological Devices Market to Prosper on Back of Rising Global Burden of Gynecological Disorders, Valuation to Touch US$ 25,267.43 Mn by 2027: TMR
The market is garnering new opportunity from continuing shift to minimally invasive surgeries
In the above regard, da Vinci robotic platform and single port laparoscopic surgery (SPLS) are popular approaches
Of the various products, surgical device segment held the major share in 2018
Regionally, North America held the major share in 2018
The North America gynecological devices market is trailed by Europe
Opportunities in Asia Pacific expected to make rapid expansion during the forecast period
China a potentially lucrative country market in Asia Pacific
Minimally Invasive Devices Market 2020 | Demand, Revenue, Key Findings and Latest Technology, Forecast Research Report 2022
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Worldwide Endometrial Cancer Market 2020- Size, Share, Opportunity, Comprehensive Analysis and Industry Forecast From 2018 – 2023
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Share:
ResearchAndMarkets.com s offering.
The publisher brings years of research experience to the 6th edition of this report. The 277-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Lung Cancer Surgery Market to Reach $37.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Lung Cancer Surgery estimated at US$25.5 Billion in the year 2020, is projected to reach a revised size of US$37.4 Billion by 2027, growing at a CAGR of 5.6% over the period 2020-2027.
Thoracotomy, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$26.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Minimally Invasive Surgeries segment is readjusted to a revised 6.2% CAGR for the next 7-year period.